Scharf Investments’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$63.9M Sell
289,373
-36,088
-11% -$9.98M 2.11% 20
2026
Q1
$96.1M Sell
325,461
-65,554
-17% -$19.5M 2.96% 14
2025
Q4
$107M Sell
391,015
-31,055
-7% -$8.44M 2.87% 14
2025
Q3
$114M Sell
422,070
-18,159
-4% -$4.94M 2.87% 14
2025
Q2
$121M Sell
440,229
-1,949
-0.4% -$530K 3.49% 12
2025
Q1
$117M Sell
442,178
-8,644
-2% -$2.13M 3.55% 14
2024
Q4
$105M Sell
450,822
-16,296
-3% -$3.75M 3.1% 15
2024
Q3
$103M Buy
+467,118
New +$96.7M 2.84% 17

Other funds holding CME

Scharf Investments's CME Position: Q2 2026 in Review

Scharf Investments reduced its CME Group (CME) stake by 11% in Q2 2026, selling an estimated $9.98M and leaving 289,373 shares worth $63.9M. The position accounts for 2.11% of the portfolio, ranked #20.

Scharf Investments first reported a position in CME in Q3 2024 and has held it in 8 quarters since. The position peaked at $121M in Q2 2025. 219 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Scharf Investments held 289,373 shares of CME Group worth $63.9M as of Q2 2026.
  • Scharf Investments sold 36,088 CME Group shares in Q2 2026, an estimated $9.98M.
  • CME Group made up 2.11% of Scharf Investments's portfolio in Q2 2026, its #20 holding.
  • Scharf Investments first reported a position in CME Group in Q3 2024 and has held it in 8 quarters since.
  • Scharf Investments's CME Group position peaked at $121M in Q2 2025.
  • 219 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Scharf Investments's 13F filing for Q2 2026, filed 13 Jul 2026.